| Literature DB >> 27956535 |
Arnel Pallera1, Jessica K Altman1, Ellin Berman1, Camille N Abboud1, Bhavana Bhatnagar1, Peter Curtin1, Daniel J DeAngelo1, Jason Gotlib1, R Tanner Hagelstrom1, Gabriela Hobbs1, Madan Jagasia1, Hagop M Kantarjian1, Patricia Kropf1, Leland Metheny1, Joseph O Moore1, Evelena Ontiveros1, Enkhtsetseg Purev1, Albert Quiery1, Vishnu V B Reddy1, Michal G Rose1, Neil P Shah1, B Douglas Smith1, David S Snyder1, Kendra L Sweet1, Raoul Tibes1, David T Yang1, Kristina Gregory1, Hema Sundar1, Michael Deininger1, Jerald P Radich1.
Abstract
The NCCN Guidelines for Chronic Myeloid Leukemia (CML) provide recommendations for the management of chronic-phase and advanced-phase CML in adult patients. The median age of disease onset is 67 years. However, because CML occurs in all age groups, clinical care teams should be prepared to address issues relating to fertility and pregnancy with patients who are of reproductive age at the time of diagnosis. CML is relatively rare in children and there are no evidence-based recommendations for the management of CML in pediatric population. These NCCN Guidelines Insights discuss special considerations for the management of CML during pregnancy and for the management of CML in the pediatric population.Entities:
Mesh：
Substances：
Year: 2016 PMID： 27956535 DOI： 10.6004/jnccn.2016.0162
Source DB: PubMed Journal: J Natl Compr Canc Netw ISSN： 1540-1405 Impact factor: 11.908